Shunyi Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shunyi Lu has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Lei Huang
Department of Orthopedic Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
5 shared publicationsHuilin Yang
Department of Orthopedic Surgery, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China
4 shared publications- Jiayi Wang
Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
4 shared publications Peng Yang
Department of Orthopedic Surgery, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China
4 shared publications- Jian Zhang
Department of Orthopedics, Zhongshan Hospital, Fudan University, Shanghai, China
3 shared publications Xingdong Xiang
Department of Orthopedic, Zhongshan Hospital, Fudan University, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
Regulated cell death: Novel targets for peripheral nerve injury
Peripheral nerve injury represents a prevalent clinical disorder, arising from diverse etiologies, including trauma, compression, iatrogenic procedures, and metabolic disorders, and manifests clinically as sensory loss, motor dysfunction, and neuropathic pain. Clinically, peripheral nerve injury profoundly impair quality of life of patients and impose a heavy socioeconomic burden. Accumulating experimental and clinical evidence has underscored the pivotal involvement of regulated cell death in mediating the pathological progression and tissue damage following peripheral nerve injury. This review systematically summarizes recent advances in understanding multiple regulated cell death modalities, including apoptosis, autophagy, pyroptosis, ferroptosis, necroptosis, and cuproptosis, in the context of peripheral nerve injury. Detailed analysis is conducted on the core molecular mechanisms governing each regulated cell death pathway, as well as their distinct cell-type-specific regulatory roles in Schwann cells, neurons, macrophages and other related cells. We also discuss the intricate crosstalk that links these death programs into an integrated signaling network, in which shared regulators such as oxidative stress, mitochondrial dysfunction, and inflammatory mediators and reciprocal modulation collectively shape the pathological course and repair outcomes following peripheral nerve injury. Furthermore, current preclinical and translational therapeutic strategies targeting regulated cell death cascades are systematically evaluated. Notably, these regulated cell death modalities function in an interconnected rather than independent manner, with integrated signaling networks collectively determining the severity of pathological injury and the efficiency of neural repair. A thorough elucidation of the precise regulatory mechanisms underlying regulated cell death is critical for the identification of innovative therapeutic targets and the development of precision medicine strategies to enhance functional recovery in patients with peripheral nerve injury.
- 17 November 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
Open AccessRegulated cell death: Novel targets for peripheral nerve injury
Peripheral nerve injury represents a prevalent clinical disorder, arising from diverse etiologies, including trauma, compression, iatrogenic procedures, and metabolic disorders, and manifests clinically as sensory loss, motor dysfunction, and neuropathic pain. Clinically, peripheral nerve injury profoundly impair quality of life of patients and impose a heavy socioeconomic burden. Accumulating experimental and clinical evidence has underscored the pivotal involvement of regulated cell death in mediating the pathological progression and tissue damage following peripheral nerve injury. This review systematically summarizes recent advances in understanding multiple regulated cell death modalities, including apoptosis, autophagy, pyroptosis, ferroptosis, necroptosis, and cuproptosis, in the context of peripheral nerve injury. Detailed analysis is conducted on the core molecular mechanisms governing each regulated cell death pathway, as well as their distinct cell-type-specific regulatory roles in Schwann cells, neurons, macrophages and other related cells. We also discuss the intricate crosstalk that links these death programs into an integrated signaling network, in which shared regulators such as oxidative stress, mitochondrial dysfunction, and inflammatory mediators and reciprocal modulation collectively shape the pathological course and repair outcomes following peripheral nerve injury. Furthermore, current preclinical and translational therapeutic strategies targeting regulated cell death cascades are systematically evaluated. Notably, these regulated cell death modalities function in an interconnected rather than independent manner, with integrated signaling networks collectively determining the severity of pathological injury and the efficiency of neural repair. A thorough elucidation of the precise regulatory mechanisms underlying regulated cell death is critical for the identification of innovative therapeutic targets and the development of precision medicine strategies to enhance functional recovery in patients with peripheral nerve injury.
- Open Access
- 24 October 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
Metabolic–epigenetic coupling links glycolysis to macrophage–mediated myelin clearance after peripheral nerve injury
Macrophages are essential for myelin clearance following peripheral nerve injury, yet the mechanisms linking their functional heterogeneity to metabolic regulation remain unclear. Single-cell RNA sequencing was combined with functional assays to characterize macrophage heterogeneity and investigate the relationship between metabolic reprogramming and myelin clearance after peripheral nerve injury. A distinct macrophage subset enriched was identified after injury that exhibited elevated expression of glycolysis-related and phagocytosis-associated genes. Functional analyses demonstrated that glycolytic activity was positively associated with macrophage-mediated myelin clearance. Among candidate regulators, solute carrier family 2 member 6 was highly expressed in this subset, and its knockdown impaired glycolysis, lactate production, histone lactylation and myelin clearance capacity, effects that were partially rescued by metabolic intervention or lactate supplementation. In vivo , lactate administration was associated with enhanced myelin clearance and improved nerve structural and functional recovery. These findings provide new insights into the interplay between metabolic reprogramming and immune function in nerve injury. These results provide a mechanistic foundation for the development of metabolism-targeted therapeutic strategies to enhance peripheral nerve regeneration.
- 24 October 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
Open AccessMetabolic–epigenetic coupling links glycolysis to macrophage–mediated myelin clearance after peripheral nerve injury
Macrophages are essential for myelin clearance following peripheral nerve injury, yet the mechanisms linking their functional heterogeneity to metabolic regulation remain unclear. Single-cell RNA sequencing was combined with functional assays to characterize macrophage heterogeneity and investigate the relationship between metabolic reprogramming and myelin clearance after peripheral nerve injury. A distinct macrophage subset enriched was identified after injury that exhibited elevated expression of glycolysis-related and phagocytosis-associated genes. Functional analyses demonstrated that glycolytic activity was positively associated with macrophage-mediated myelin clearance. Among candidate regulators, solute carrier family 2 member 6 was highly expressed in this subset, and its knockdown impaired glycolysis, lactate production, histone lactylation and myelin clearance capacity, effects that were partially rescued by metabolic intervention or lactate supplementation. In vivo , lactate administration was associated with enhanced myelin clearance and improved nerve structural and functional recovery. These findings provide new insights into the interplay between metabolic reprogramming and immune function in nerve injury. These results provide a mechanistic foundation for the development of metabolism-targeted therapeutic strategies to enhance peripheral nerve regeneration.
- 2 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Chemo-metallo nanodrivers for spatiotemporally controlled in situ vaccination
In situ cancer vaccines exhibit promising therapeutic potential; however, their efficacy is constrained by limited antigen release, suboptimal spatiotemporal immune coordination, and adaptive immune resistance. In this study, we identify zinc ions (Zn 2+ ) as synergistic agents with chemotherapeutics in modulating PANoptosis and immune signaling pathways. Capitalizing on this concept, a chemo-metallic nanodriver was developed for effective in situ cancer vaccination. This system used zinc-aluminum layered double hydroxides as the structural base and efficiently loaded cisplatin (DDP) and indocyanine green via coordination-driven polymerization, forming a spatiotemporally controllable nanodriver, which facilitated the simultaneous release of drug and metal ions upon photoactivation. The released Zn 2+ specifically disrupted zinc homeostasis in tumor cells, inducing mitochondrial dysfunction. This effect acted in concert with DDP-mediated DNA damage, not only effectively activating the cGAS-STING (cyclic GMP-AMP synthase–stimulator of interferon genes) pathway but also promoting the assembly and activation of AIM2-PANoptosome complex to execute PANoptosis. This STING-PANoptosis cascade led to a burst release of damage-associated molecular patterns, markedly enhanced dendritic cell maturation, and stimulated the secretion of pro-inflammatory cytokines. Furthermore, the nanodriver elicited a robust antitumor immune response and established durable immune memory in mouse models. These findings not only provide an optimized strategy for precise immunotherapy of gastric cancer but also increase the understanding of the applications of metal ion immunology and PANoptosis in disease intervention.
- 2 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Chemo-metallo nanodrivers for spatiotemporally controlled in situ vaccination
In situ cancer vaccines exhibit promising therapeutic potential; however, their efficacy is constrained by limited antigen release, suboptimal spatiotemporal immune coordination, and adaptive immune resistance. In this study, we identify zinc ions (Zn 2+ ) as synergistic agents with chemotherapeutics in modulating PANoptosis and immune signaling pathways. Capitalizing on this concept, a chemo-metallic nanodriver was developed for effective in situ cancer vaccination. This system used zinc-aluminum layered double hydroxides as the structural base and efficiently loaded cisplatin (DDP) and indocyanine green via coordination-driven polymerization, forming a spatiotemporally controllable nanodriver, which facilitated the simultaneous release of drug and metal ions upon photoactivation. The released Zn 2+ specifically disrupted zinc homeostasis in tumor cells, inducing mitochondrial dysfunction. This effect acted in concert with DDP-mediated DNA damage, not only effectively activating the cGAS-STING (cyclic GMP-AMP synthase–stimulator of interferon genes) pathway but also promoting the assembly and activation of AIM2-PANoptosome complex to execute PANoptosis. This STING-PANoptosis cascade led to a burst release of damage-associated molecular patterns, markedly enhanced dendritic cell maturation, and stimulated the secretion of pro-inflammatory cytokines. Furthermore, the nanodriver elicited a robust antitumor immune response and established durable immune memory in mouse models. These findings not only provide an optimized strategy for precise immunotherapy of gastric cancer but also increase the understanding of the applications of metal ion immunology and PANoptosis in disease intervention.
- Top Cited PapersOpen Access
- 30 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Pyroptosis-responsive microspheres modulate the inflammatory microenvironment to retard osteoporosis in female mice
The treatment of osteoporosis and related bone defects remains challenging. This study identifies pyroptosis-driven inflammation as a key disruptor of bone homeostasis. To address this, we develop a magnesium-gelatin composite microsphere scaffold (GelMa/Mg/DMF MS) that exploit pyroptosis blockade and hydrogen-mediated inflammation regulation for osteoporosis treatment. This porous microsphere scaffold is implanted into bone defects to achieve the sustained release of hydrogen gas, magnesium ions (Mg2+), and dimethyl fumarate (DMF). DMF act by activating the nuclear factor erythroid-related factor 2 to prevent osteoblast pyroptosis, and combine with the antioxidant effects of hydrogen, effectively remodel the inflammatory microenvironment and create favorable conditions for the restoration of bone homeostasis. Mg2+ further expedite bone tissue repair. These results demonstrate that the GelMa/Mg/DMF MS effectively reverse inflammatory microenvironments both in vivo and in vitro, resulting in significant tissue repair. These results suggest the combination of hydrogen therapy and pyroptosis blockade as a potential therapeutic strategy.
- 30 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Top Cited PapersOpen AccessPyroptosis-responsive microspheres modulate the inflammatory microenvironment to retard osteoporosis in female mice
The treatment of osteoporosis and related bone defects remains challenging. This study identifies pyroptosis-driven inflammation as a key disruptor of bone homeostasis. To address this, we develop a magnesium-gelatin composite microsphere scaffold (GelMa/Mg/DMF MS) that exploit pyroptosis blockade and hydrogen-mediated inflammation regulation for osteoporosis treatment. This porous microsphere scaffold is implanted into bone defects to achieve the sustained release of hydrogen gas, magnesium ions (Mg2+), and dimethyl fumarate (DMF). DMF act by activating the nuclear factor erythroid-related factor 2 to prevent osteoblast pyroptosis, and combine with the antioxidant effects of hydrogen, effectively remodel the inflammatory microenvironment and create favorable conditions for the restoration of bone homeostasis. Mg2+ further expedite bone tissue repair. These results demonstrate that the GelMa/Mg/DMF MS effectively reverse inflammatory microenvironments both in vivo and in vitro, resulting in significant tissue repair. These results suggest the combination of hydrogen therapy and pyroptosis blockade as a potential therapeutic strategy.
- Open Access
- 25 June 2025
- Published by Wolters Kluwer Health in Regenerative Medicine Reports
- Vol. 2 (4) , 143-148
Association between relative fat mass and lumbar bone mineral density in US adults: a cross-sectional study of the National Health and Nutrition Examination Survey 2011–2018
JOURNAL/rmrep/04.03/02273995-202512000-00002/figure1/v/2026-04-22T111838Z/r/image-tiff The relationship between obesity and bone health remains controversial, with extensive studies suggesting associations; however, the precise nature of this relationship remains uncertain. Relative fat mass (RFM) is an innovative obesity metric that provides a more precise evaluation of body fat distribution than conventional methods, but its implications for skeletal health remain unexplored. This study aimed to explore the relationship between RFM and lumbar bone mineral density (BMD) in adults from 2011–2018. Weighted multivariate logistic regression, subgroup analysis, and interaction tests were employed to examine the relationship between RFM and lumbar BMD, utilizing data derived from the 2011–2018 National Health and Nutrition Examination Survey. This study included a total of 11,410 participants. Weighted multiple linear regression analysis revealed a significant negative correlation between RFM and lumbar BMD among adults aged 20–59 years. This negative correlation persisted even when RFM was analyzed by quartiles, with individuals in the highest RFM quartile exhibiting lumbar BMD levels 0.046 g/cm 2 lower than those in the lowest quartile. However, the results of the subgroup analysis suggested that this negative association was abolished in individuals with diabetes, hypertension, or chronic kidney disease but was not significantly influenced by factors such as sex and race. Our findings indicate a significant negative correlation between RFM and lumbar BMD in US adults aged 20–59 years, with notable attenuation in specific clinical populations, offering fresh perspectives and research targets for clinical analysis.
- 25 June 2025
- Published by Wolters Kluwer Health in Regenerative Medicine Reports
- Vol. 2 (4) , 143-148
Open AccessAssociation between relative fat mass and lumbar bone mineral density in US adults: a cross-sectional study of the National Health and Nutrition Examination Survey 2011–2018
JOURNAL/rmrep/04.03/02273995-202512000-00002/figure1/v/2026-04-22T111838Z/r/image-tiff The relationship between obesity and bone health remains controversial, with extensive studies suggesting associations; however, the precise nature of this relationship remains uncertain. Relative fat mass (RFM) is an innovative obesity metric that provides a more precise evaluation of body fat distribution than conventional methods, but its implications for skeletal health remain unexplored. This study aimed to explore the relationship between RFM and lumbar bone mineral density (BMD) in adults from 2011–2018. Weighted multivariate logistic regression, subgroup analysis, and interaction tests were employed to examine the relationship between RFM and lumbar BMD, utilizing data derived from the 2011–2018 National Health and Nutrition Examination Survey. This study included a total of 11,410 participants. Weighted multiple linear regression analysis revealed a significant negative correlation between RFM and lumbar BMD among adults aged 20–59 years. This negative correlation persisted even when RFM was analyzed by quartiles, with individuals in the highest RFM quartile exhibiting lumbar BMD levels 0.046 g/cm 2 lower than those in the lowest quartile. However, the results of the subgroup analysis suggested that this negative association was abolished in individuals with diabetes, hypertension, or chronic kidney disease but was not significantly influenced by factors such as sex and race. Our findings indicate a significant negative correlation between RFM and lumbar BMD in US adults aged 20–59 years, with notable attenuation in specific clinical populations, offering fresh perspectives and research targets for clinical analysis.
- Open Access
- 12 May 2025
- Published by Wolters Kluwer Health in Regenerative Medicine Reports
- Vol. 2 (3) , 100-107
Ferroptosis in osteogenic differentiation: a narrative review of bone regeneration metabolism
Bone healing is a complex multifactor and diverse physiological process. In terms of osteogenic differentiation, different types of regulated cell death, such as ferroptosis, play key roles in the bone microenvironment. Ferroptosis is a new type of regulated cell death discovered in 2012. It is characterized by lipid peroxidation and iron-dependent accumulation, which are closely related to various clinical challenges. In recent years, an increasing number of studies have indicated a strong potential relationship between ferroptosis and different orthopedic diseases, including osteoporosis, osteopenia and osteoarthritis. Hence, an in-depth investigation of the relationship between ferroptosis and bone metabolism is highly important for the treatment of orthopedic diseases. Moreover, ferroptosis is also accompanied by morphological changes in mitochondria, such as increased membrane density and shrunken mitochondria, which have been detected in osteoblasts, bone marrow stem mesenchymal cells and osteoclasts. The inhibition of ferroptosis can reduce mitochondrial damage, alleviate oxidative stress and promote bone regeneration. This article reviews the mechanism of ferroptosis from the aspects of iron overload and the regulation of ferroptosis-related pathways, as well as their effects on bone regeneration. Increasing evidence has shown that bone defect healing and bone regeneration processes are closely related to abnormal iron metabolism. Inhibiting ferroptosis in bone marrow mesenchymal stem cells or osteoblasts can effectively improve the bone healing rate and promote bone regeneration progression. We discuss the detailed mechanism of ferroptosis and summarize the current research on ferroptosis and bone disease treatment.
- 12 May 2025
- Published by Wolters Kluwer Health in Regenerative Medicine Reports
- Vol. 2 (3) , 100-107
Open AccessFerroptosis in osteogenic differentiation: a narrative review of bone regeneration metabolism
Bone healing is a complex multifactor and diverse physiological process. In terms of osteogenic differentiation, different types of regulated cell death, such as ferroptosis, play key roles in the bone microenvironment. Ferroptosis is a new type of regulated cell death discovered in 2012. It is characterized by lipid peroxidation and iron-dependent accumulation, which are closely related to various clinical challenges. In recent years, an increasing number of studies have indicated a strong potential relationship between ferroptosis and different orthopedic diseases, including osteoporosis, osteopenia and osteoarthritis. Hence, an in-depth investigation of the relationship between ferroptosis and bone metabolism is highly important for the treatment of orthopedic diseases. Moreover, ferroptosis is also accompanied by morphological changes in mitochondria, such as increased membrane density and shrunken mitochondria, which have been detected in osteoblasts, bone marrow stem mesenchymal cells and osteoclasts. The inhibition of ferroptosis can reduce mitochondrial damage, alleviate oxidative stress and promote bone regeneration. This article reviews the mechanism of ferroptosis from the aspects of iron overload and the regulation of ferroptosis-related pathways, as well as their effects on bone regeneration. Increasing evidence has shown that bone defect healing and bone regeneration processes are closely related to abnormal iron metabolism. Inhibiting ferroptosis in bone marrow mesenchymal stem cells or osteoblasts can effectively improve the bone healing rate and promote bone regeneration progression. We discuss the detailed mechanism of ferroptosis and summarize the current research on ferroptosis and bone disease treatment.
- Open Access
- 26 April 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 52, 249-264
Neuromuscular electrical stimulation alleviates stroke-related sarcopenia by promoting satellite cells myogenic differentiation via AMPK-ULK1-Autophagy axis
- 26 April 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 52, 249-264
Open AccessNeuromuscular electrical stimulation alleviates stroke-related sarcopenia by promoting satellite cells myogenic differentiation via AMPK-ULK1-Autophagy axis
- Open Access
- 25 May 2024
- Published by Elsevier in Materials Today Bio
- Vol. 26, 101092
Injectable and high-strength PLGA/CPC loaded ALN/MgO bone cement for bone regeneration by facilitating osteogenesis and inhibiting osteoclastogenesis in osteoporotic bone defects
- 25 May 2024
- Published by Elsevier in Materials Today Bio
- Vol. 26, 101092
Open AccessInjectable and high-strength PLGA/CPC loaded ALN/MgO bone cement for bone regeneration by facilitating osteogenesis and inhibiting osteoclastogenesis in osteoporotic bone defects
- Open Access
- 25 April 2023
- Published by Wiley in Mediators of Inflammation
- Vol. 2023, 1-12
Inhibition of Schwann Cell Pyroptosis Promotes Nerve Regeneration in Peripheral Nerve Injury in Rats
Background. Peripheral nerve injury (PNI) is one of the most debilitating injuries, but therapies for PNI are still far from satisfactory. Pyroptosis, a recently identified form of cell death, has been demonstrated to participate in different diseases. However, the role of pyroptosis of Schwann cells in PNI remains unclear. Methods. We established a rat PNI model, and western blotting, transmission electron microscopy, and immunofluorescence staining were used to confirm pyroptosis of Schwann cells in PNI in vivo. In vitro, pyroptosis of Schwann cells was induced by lipopolysaccharides (LPS)+adenosine triphosphate disodium (ATP). An irreversible inhibitor of pyroptosis, acetyl (Ac)-Tyr-Val-Ala-Asp-chloromethyl ketone (Ac-YVAD-cmk), was used to attenuate Schwann cell pyroptosis. Moreover, the influence of pyroptotic Schwann cells on the function of dorsal root ganglion neurons (DRGns) was analyzed by a coculture system. Finally, the rat PNI model was intraperitoneally treated with Ac-YVAD-cmk to observe the effect of pyroptosis on nerve regeneration and motor function. Results. Schwann cell pyroptosis was notably observed in the injured sciatic nerve. LPS+ATP treatment effectively induced Schwann cell pyroptosis, which was largely attenuated by Ac-YVAD-cmk. Additionally, pyroptotic Schwann cells inhibited the function of DRGns by secreting inflammatory factors. A decrease in pyroptosis in Schwann cells promoted regeneration of the sciatic nerve and recovery of motor function in rats. Conclusion. Given the role of Schwann cell pyroptosis in PNI progression, inhibition of Schwann cell pyroptosis might be a potential therapeutic strategy for PNI in the future.
- 25 April 2023
- Published by Wiley in Mediators of Inflammation
- Vol. 2023, 1-12
Open AccessInhibition of Schwann Cell Pyroptosis Promotes Nerve Regeneration in Peripheral Nerve Injury in Rats
Background. Peripheral nerve injury (PNI) is one of the most debilitating injuries, but therapies for PNI are still far from satisfactory. Pyroptosis, a recently identified form of cell death, has been demonstrated to participate in different diseases. However, the role of pyroptosis of Schwann cells in PNI remains unclear. Methods. We established a rat PNI model, and western blotting, transmission electron microscopy, and immunofluorescence staining were used to confirm pyroptosis of Schwann cells in PNI in vivo. In vitro, pyroptosis of Schwann cells was induced by lipopolysaccharides (LPS)+adenosine triphosphate disodium (ATP). An irreversible inhibitor of pyroptosis, acetyl (Ac)-Tyr-Val-Ala-Asp-chloromethyl ketone (Ac-YVAD-cmk), was used to attenuate Schwann cell pyroptosis. Moreover, the influence of pyroptotic Schwann cells on the function of dorsal root ganglion neurons (DRGns) was analyzed by a coculture system. Finally, the rat PNI model was intraperitoneally treated with Ac-YVAD-cmk to observe the effect of pyroptosis on nerve regeneration and motor function. Results. Schwann cell pyroptosis was notably observed in the injured sciatic nerve. LPS+ATP treatment effectively induced Schwann cell pyroptosis, which was largely attenuated by Ac-YVAD-cmk. Additionally, pyroptotic Schwann cells inhibited the function of DRGns by secreting inflammatory factors. A decrease in pyroptosis in Schwann cells promoted regeneration of the sciatic nerve and recovery of motor function in rats. Conclusion. Given the role of Schwann cell pyroptosis in PNI progression, inhibition of Schwann cell pyroptosis might be a potential therapeutic strategy for PNI in the future.